Good that it bounced from a temporary sell off after the initial rise. Hopefully as the news spreads finally some investors will re-assess and put money in or back in. The ramifications for the OTC lines is huge IMO - they now have a body of scientific evidence to back up the marketing - not just lab tests and here say. I've been bemused with the BB as other have but perhaps there has been some barrier's with the news flow and hopefully they can continue with it towards more reasonable valuations above $20?? Today's action might come under notice as well. GLTA
Ann: Afamelanotide Assists DNA Repair Response Following UVR, page-10
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.58 |
Change
-0.100(0.73%) |
Mkt cap ! $679.8M | |||
| Open | High | Low | Value | Volume |
| $13.75 | $13.90 | $13.34 | $1.163M | 86.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 905 | $13.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.60 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |